Apollo Therapeutics Secures $226.5 Million for Advancing Med

Company founded by the tech transfer offices of Imperial, Cambridge and UCL has raised major Series C funding to turn basic research into medicines.Apollo’s new funding is great news for pharmaceutical innovation in the UK. It’s also a vote of confid

Related Keywords

London , City Of , United Kingdom , Cambridge , Cambridgeshire , Vjera Magdalenic Moussavi , Matthew Fuchter , Sebastian Johnston , Martin Wilkins , Holger Auner , Simon Hepworth , Richard Mason , Institute Of Cancer Research , Enterprise At Imperial College London , National Heart , Department Of Chemistry , University Of Cambridge , Imperial Department Of Immunology , Imperial College London , King College London , Lung Institute , Imperial College , Patient Square Capital , Chief Executive Officer , Apollo Therapeutics , Professor Sebastian Johnston , Professor Holger Auner , Professor Matthew Fuchter , Professor Martin Wilkins , Professor Lan Zhao , Industry Partnerships , Rock Springs Capital , College London ,